ContraFect Corporation

07/20/2020 | Press release | Distributed by Public on 07/20/2020 05:34

ContraFect Announces up to $18.9 Million in Funding from CARB-X to Support Acceleration of the CF-370 Program for Treating Pseudomonas aeruginosa Infections towards Clinical[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.